Pdt Partners, LLC Neoleukin Therapeutics, Inc. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.25 $10,344 - $25,299	-11,244 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.72 - $5.23 $48,534 - $147,580	-28,218 Reduced 71.51%	11,244 $21,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.75 $86,899 - $144,832	18,688 Added 89.96%	39,462 $190,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $9.66 $125,682 - $200,676	20,774 New	20,774 $150,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.